合理利用肿瘤标志物及伴随诊断促进个体化医疗

Rinsho byori. The Japanese journal of clinical pathology Pub Date : 2017-03-01

Shuji Tohda

{"title":"合理利用肿瘤标志物及伴随诊断促进个体化医疗","authors":"Shuji Tohda","doi":"","DOIUrl":null,"url":null,"abstract":"Standardization based on clinical guidelines and personalization by molecular-targeted therapy have been introduced into the field of cancer treatment. To select patients appropriate for molecular-targeted drugs, various companion diagnostics have been developed. To catch up with revision of the clinical guidelines and progress of companion diagnostics, the effective utilization of \"Guidelines for clinical examinations JSLM2015\" is desirable. [Review].","PeriodicalId":21457,"journal":{"name":"Rinsho byori. The Japanese journal of clinical pathology","volume":"65 3","pages":"314-316"},"PeriodicalIF":0.0000,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Promotion of Personalized Medicine by Appropriate Utilization of Tumor Markers and Companion Diagnostics].\",\"authors\":\"Shuji Tohda\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Standardization based on clinical guidelines and personalization by molecular-targeted therapy have been introduced into the field of cancer treatment. To select patients appropriate for molecular-targeted drugs, various companion diagnostics have been developed. To catch up with revision of the clinical guidelines and progress of companion diagnostics, the effective utilization of \\\"Guidelines for clinical examinations JSLM2015\\\" is desirable. [Review].\",\"PeriodicalId\":21457,\"journal\":{\"name\":\"Rinsho byori. The Japanese journal of clinical pathology\",\"volume\":\"65 3\",\"pages\":\"314-316\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rinsho byori. The Japanese journal of clinical pathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rinsho byori. The Japanese journal of clinical pathology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

基于临床指南的标准化和分子靶向治疗的个性化已被引入癌症治疗领域。为了选择适合分子靶向药物的患者，已经开发了各种伴随诊断。为了跟上临床指南的修订和伴随诊断的进展，需要有效利用《临床检查指南JSLM2015》。(审查)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[Promotion of Personalized Medicine by Appropriate Utilization of Tumor Markers and Companion Diagnostics].

Standardization based on clinical guidelines and personalization by molecular-targeted therapy have been introduced into the field of cancer treatment. To select patients appropriate for molecular-targeted drugs, various companion diagnostics have been developed. To catch up with revision of the clinical guidelines and progress of companion diagnostics, the effective utilization of "Guidelines for clinical examinations JSLM2015" is desirable. [Review].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Rinsho byori. The Japanese journal of clinical pathology

自引率

0.00%

发文量